Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0222906 SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines,...
2018/0222905 NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A
The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess...
2018/0222904 BRUTON'S TYROSINE KINASE INHIBITORS
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I): ##STR00001##
2018/0222903 NEW CRYSTALLINE FORM AND ACETIC ACID ADDUCTS OF PALBOCICLIB
The present invention relates to an adduct of palbociclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.
2018/0222902 DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA
Provided are novel compounds of Formula (I): ##STR00001## pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in...
2018/0222901 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The...
2018/0222900 N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS
A novel class of inhibitors of protein kinases that are useful in the treatment of cell proliferative diseases and conditions, and especially those...
2018/0222899 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION
The present invention relates to certain bis-heteroaryl compounds, pharmaceutical compositions containing them, and methods of using them, including methods...
2018/0222898 NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL
Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and...
2018/0222897 SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK AND THEIR PREPARATION AND USE IN THE TREATMENT OF CANCER,...
Compounds of Formula I, as shown below and defined herein: ##STR00001## and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and...
2018/0222896 HETEROCYCLIC COMPOUND
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of autoimmune diseases and/or inflammatory...
2018/0222895 COMPOUNDS FOR USE IN PREPARING HETEROCYCLIC TRIAZOLE AGONISTS OF THE APJ RECEPTOR
Compounds of Formula V, salts thereof, tautomers thereof, and salts of the tautomers have the following structure and are useful compounds in preparing small...
2018/0222894 N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors And Their Use Thereof
A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof: ##STR00001## Compounds of...
2018/0222893 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
The present invention encompasses compounds of the formula (I) ##STR00001## wherein the groups R.sub.1, Cy and Y are defined herein, which are suitable for the...
2018/0222892 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS
Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such...
2018/0222891 3-(1H-INDOL-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF
Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole...
2018/0222890 5-(N-[6,5]-FUSED BICYCLIC ARYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS...
Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the...
2018/0222889 NOVEL SUBSTITUTED GLYCINE DERIVED FXIA INHIBITORS
The present invention provides compounds of Formula (I): [INSERT CHEMICAL STRUCTURE HERE] (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts...
2018/0222888 COMPOUNDS USEFUL FOR TREATING CANCER
The present invention relates to a compound of formula (I): ##STR00001## wherein A and A' independently represent a phenylene group or a pyridylene group;...
2018/0222887 ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF
Isoquinoline compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an...
2018/0222886 VINYL COMPOUNDS AS FGFR AND VEGFR INHIBITORS
FGFR and VEGFR inhibitors are provided, and compounds represented by formula (1) or formula (II) as FGFR and VEGFR inhibitors, pharmaceutically acceptable...
2018/0222885 MUSCARINIC AGONISTS
This invention relates to compounds that are agonists of the muscarinic M.sub.1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic...
2018/0222884 METALLOENZYME INHIBITOR COMPOUNDS
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by...
2018/0222883 HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA
Disclosed are compounds of Formula (I) or a salt thereof, wherein: A is CR.sub.1 or N; B is CR.sub.3 or N; D is CR.sub.4 or N; L.sub.1 is ...
2018/0222882 PYRIDAZINE DERIVATIVES AS RORc MODULATORS
Compounds of formula I: ##STR00001## or pharmaceutical salts thereof, wherein m, n, A, R1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as defined herein. Also...
2018/0222880 SecA INHIBITORS AND METHODS OF MAKING AND USING THEREOF
Inhibitors of SecA, and methods of making and using thereof, are described herein. The compounds described herein can be used to treat or prevent microbial...
2018/0222879 Methods of Purifying Cannabinoids, Compositions and Kits Thereof
The present specification discloses methods of purifying one or more cannabinoids from a plant material, purified cannabinoids and pharmaceutical compositions...
2018/0222878 COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES
The present invention relates to a composition for inhibiting the formation of a SNARE complex, containing myricetin derivatives, and having novel structures...
2018/0222877 PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND ESTERS THEREOF
A process for producing furan dicarboxylic acid or an ester thereof from a feedstock comprising hydroxymethyl furfural (HMF) and humins is disclosed. Humins...
2018/0222876 VINYL FLUORIDE CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general...
2018/0222875 METHOD FOR PREPARING 2-MERCAPTOBENZOTHIAZOLE
A method for preparing 2-mercaptobenzothiazole where the aniline method is adopted to perform reaction in the presence of a catalyst, and the catalyst includes...
2018/0222874 MODULATORS OF MYOCYTE LIPID ACCUMULATION AND INSULIN RESISTANCE AND METHODS OF USE THEREOF
Formulations and methods for reducing blood glucose and/or increasing insulin signaling in a subject have been developed. The formulations include SBI-477 and...
2018/0222873 METHOD FOR PREPARING 3-TRIFLUOROMETHYL CHALCONES
Disclosed is a method for preparing a compound of Formula 1 wherein Q and Z are as defined in the disclosure comprising distilling water from a mixture...
2018/0222872 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
Fluorene derivatives that are connected in one or more of the 1-, 1'-, 4-, or 4'-positions in any combination to a carbon atom of a diaryl substituted...
2018/0222871 METHOD FOR PREPARING SUBSTITUTED 3-(2-ANILINO-1-CYCLOHEXYL-1H-BENZIMIDAZOL-5-YL)PROPANOIC ACID DERIVATIVES
The present invention relates to a method for preparing substituted 3-(2-anilino-1-cyclohexyl-1H-benzimidazol-5-yl)propanoic acid derivatives of the general...
2018/0222870 INHIBITOR OF THE MUTATED ISOCITRATE DEHYDROGENASE IDH1 R132H
The present invention relates to the adduct (2E)-but-2-enedioic acid-3-(2-{[4-(trifluoromethoxy)phenyl]amino}-1-[(1R,5R)-3,3,5-trimethylc- ...
2018/0222869 ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE...
A novel class of drugs for treating androgen receptor (AR) positive cancer including prostate cancer and breast cancer are described. The drugs include the...
2018/0222868 Indazole Derivatives as Modulators of TNF Activity
A series of substituted indazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of...
2018/0222867 N-SUBSTITUTED PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF
The invention provides pyrazolyl guanidine compounds that inhibit F.sub.1F.sub.0-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic...
2018/0222866 TRYPANOSOMES INHIBITORS
The invention relates to a compound of formula (I) ##STR00001## wherein R.sup.1 and R.sup.2 are defined as in the description and in the claims. The compound of...
2018/0222865 METHOD FOR PRODUCING PITAVASTATIN CALCIUM
Production of pitavastatin calcium safely on an industrial scale with a high yield and high selectivity at low cost. A method of producing pitavastatin calcium...
2018/0222864 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the...
2018/0222863 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY
What is described is a compound ##STR00001## wherein R.sub.1 and R.sub.2 are the same or different, each a linear or branched alkyl consisting of 1 to 20...
2018/0222862 NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
A compound of Formula I is provided: ##STR00001## or pharmaceutically acceptable enantiomers, salts or solvates thereof. The invention further relates to the...
2018/0222861 SYNTHESIS OF DIINDOLYLMETHANES AND INDOLO[3,2-B]CARBAZOLES, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL...
Described is a method to make diindolylmethanes and indolyl/pyrrolylmethanes, The method includes the steps of contacting an ether comprising an arylpropargyl...
2018/0222860 MODULATORS OF ROR-GAMMA
Provided are novel compounds of Formula I: pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the...
2018/0222859 Process for the Selective Production of N-Methyl-2-Pyrrolidone (NMP)
This invention relates to an improved process for the selective production of N-methyl pyrrolidone (NMP) from gamma-butyrolactone and monomethyl amine...
2018/0222858 DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
The present invention concerns a compound of following formula (I): where: --R.sub.1 is H or OH, --R.sub.2 is a (C.sub.1-C.sub.6)alkyl, COOH, ...
2018/0222857 ARYL SULFONOHYDRAZIDES
Compound of formula I: ##STR00001## wherein: A is selected from: (i) ##STR00002## where R.sup.F1 is H or F; (ii) ##STR00003## (iii) a N-containing C.sub.6...
2018/0222856 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE
Disclosed are novel compounds--benzenesulfonamides of general formulas (I) and ##STR00001## The compounds can be used in biomedicine as active ingredients in ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.